Home » Psychology news » Long-term varenicline treatment supports tobacco abstinence in people with mental illness
Long-term varenicline treatment supports tobacco abstinence in people with mental illness
January 8, 2014 by NewsBot
Extended treatment with the smoking cessation drug varenicline significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment.
